NASDAQ: LBPH - Longboard Pharmaceuticals, Inc.

Yield per half year: +238.76%
Sector: Healthcare

Current price
58.86 $
Average price
28.42 $ -51.72%

Average analyst price
60 $ +1.94%
Price based on EPS
24.75 $ -57.95%
3.33/10

Average analyst price

Fair price = 60 $
Current price = 58.86 $ (difference = +1.94%)

Idea Price forecast Changes Expiration date Analyst
More details 60 $ +1.14 $ (1.94%) 07.01.2025 Baird

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 24.75 $
Current price = 58.86 $ (difference = -57.95%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -3.11 $
Current price = 58.86 $ (difference = -105.29%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -6.41 $
Current price = 58.86 $ (difference = -110.9%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription